Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L
Authors
Keywords
-
Journal
Applied Health Economics and Health Policy
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-12
DOI
10.1007/s40258-023-00837-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A two-step procedure to generate utilities for the Infant health-related Quality of life Instrument (IQI)
- (2020) Paul F. M. Krabbe et al. PLoS One
- An overview of the time trade-off method: concept, foundation, and the evaluation of distorting factors in putting a value on health
- (2020) Anna K. Lugnér et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Selecting Bolt-on Dimensions for the EQ-5D: Testing the Impact of Hearing, Sleep, Cognition, Energy, and Relationships on Preferences Using Pairwise Choices
- (2020) Aureliano Paolo Finch et al. MEDICAL DECISION MAKING
- Patient-Centered Item Selection for a New Preference-Based Generic Health Status Instrument: CS-Base
- (2019) Paul F.M. Krabbe et al. VALUE IN HEALTH
- United States Valuation of EQ-5D-5L Health States Using an International Protocol
- (2019) A. Simon Pickard et al. VALUE IN HEALTH
- A preference-based item response theory model to measure health: concept and mathematics of the multi-attribute preference response model
- (2018) Catharina G. M. Groothuis-Oudshoorn et al. BMC Medical Research Methodology
- Head-to-Head Comparison of EQ‐5D‐3L and EQ‐5D‐5L Health Values
- (2018) Anna Selivanova et al. PHARMACOECONOMICS
- German Value Set for the EQ-5D-5L
- (2018) Kristina Ludwig et al. PHARMACOECONOMICS
- Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries
- (2018) Mathieu F. Janssen et al. PHARMACOECONOMICS
- Valuing health-related quality of life: An EQ-5D-5L value set for England
- (2017) Nancy J. Devlin et al. HEALTH ECONOMICS
- Standardizing Patient Outcomes Measurement
- (2016) Michael E. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?
- (2016) Milad Karimi et al. PHARMACOECONOMICS
- Dutch Tariff for the Five-Level Version of EQ-5D
- (2016) Matthijs M. Versteegh et al. VALUE IN HEALTH
- Comparing the measurement equivalence of EQ-5D-5L across different modes of administration
- (2015) Brendan Mulhern et al. Health and Quality of Life Outcomes
- An Exploratory Study to Test the Impact on Three “Bolt-On” Items to the EQ-5D
- (2015) Yaling Yang et al. VALUE IN HEALTH
- Validity and Responsiveness of Preference Based Measures: A Critical Overview of Reviews
- (2015) AP Finch et al. VALUE IN HEALTH
- Do health preferences contradict ordering of EQ-5D labels?
- (2014) Benjamin M. Craig et al. QUALITY OF LIFE RESEARCH
- A Program of Methodological Research to Arrive at the New International EQ-5D-5L Valuation Protocol
- (2014) Mark Oppe et al. VALUE IN HEALTH
- A Generalized Measurement Model to Quantify Health: The Multi-Attribute Preference Response Model
- (2013) Paul F. M. Krabbe PLoS One
- Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—Eliciting Concepts for a New PRO Instrument
- (2011) Donald L. Patrick et al. VALUE IN HEALTH
- Conducting Discrete Choice Experiments to Inform Healthcare Decision Making
- (2008) Emily Lancsar et al. PHARMACOECONOMICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started